Natera Shares Real-World Analyses and Data at ASN Kidney Week 2026, Highlighting the Critical Need for Genetic Testing with Renasight™
Natera presented 18 abstracts, including three oral presentations, at ASN Kidney Week 2026 supporting its Renasight genetic test for chronic kidney disease. Real-world data showed median time from first abnormal kidney indicator to diagnosis of about 5.3 years, and only 26.6% of high-risk patients with hereditary or structural kidney disease had documented nephrology care.
Key figures
- Oral presentations
- 3
- Abstracts presented
- 18
- Median years to ckd diagnosis
- 5.3 years
- Median days to specialist referral
- 149
- High risk patients with nephrology care pct
- 26.6%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.